Antigens for diagnosing neurocysticercosis
US4855408A · kind A · utility
1Cited by
0References
2Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 27, 1988 |
| Grant date | Aug 8, 1989 |
| Priority date | — |
| Expiry date | May 27, 2008 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S530/839
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
Two substantially purified larval T. solium antigens found circulating in the cerebrospinal fluid of patients infected with T. solium, having molecular weights of 190 KD and 230 KD, are disclosed. These antigens, alone or in combination, may be used to diagnose or to follow the course of neurocysticercosis, caused by T. solium infection.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.